# Valuation of the Antioxidant and Neuroprotective Effects of CoQ10-MINIACTIVES® (COQUN® OS) in Patients Affected by Primary Open Angle Glaucoma

> **NCT04038034** · NA · UNKNOWN · sponsor: **VISUfarma SpA** · enrollment: 70 (estimated)

## Conditions studied

- Glaucoma, Open-Angle

## Interventions

- **DIETARY_SUPPLEMENT:** CoQ10- MINIACTIVES
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT04038034
- **Lead sponsor:** VISUfarma SpA
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-09-01
- **Primary completion:** 2021-08-30
- **Final completion:** 2021-08-30
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2020-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04038034

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04038034, "Valuation of the Antioxidant and Neuroprotective Effects of CoQ10-MINIACTIVES® (COQUN® OS) in Patients Affected by Primary Open Angle Glaucoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04038034. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*